Hepatitis C – Page 3 – HCV Guidance

The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997

April 9, 2018
A cluster of acute hepatitis C virus infection among men who have sex with men–results from contact tracing and public health implications

April 9, 2018
Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004

April 9, 2018
Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men–New York City, 2005-2010

April 9, 2018
Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009

April 9, 2018
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients

December 8, 2017
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus

December 8, 2017
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

September 15, 2017
Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens

September 14, 2017
Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection

September 14, 2017